FCA censures London Capital & Finance over misleading promos
By 
Kyle Brasseur2023-10-11T18:57:00
Insolvent credit broker London Capital & Finance (LCF) dodged a “substantial financial penalty” from the U.K. Financial Conduct Authority (FCA) regarding promotions it used to market minibonds to investors.
The FCA censured the firm for its “unfair and misleading” promos, the regulator announced in a press release Wednesday. Because LCF has been in administration since 2019 and its funds are being focused toward restoring bondholder creditors, the FCA opted not to fine the firm.
But the regulator criticized the firm for its “serious failings” that harmed more than 11,000 investors. The FCA said LCF would have owed restitution of about 237 million pounds (U.S. $291 million) had it been ordered to pay.
Related articles
-
News BriefFRC fines PwC, EY for London Capital & Finance audit failings
Big Four firms PwC and EY were each penalized by the Financial Reporting Council for alleged shortcomings during their respective audits at collapsed investment firm London Capital & Finance.
-
PremiumU.K. sets recommendations to address misogyny in finance
Sexism, sexual assault, and bullying are rife at financial services organizations, according to a recent report by the U.K. Treasury Committee. “The government and financial regulators have important roles to play in driving change,” the committee said.
-
News BriefFCA fines, bans ex-London Capital & Finance compliance head over promos
The U.K. Financial Conduct Authority issued a fine of £31,800 (U.S. $40,000) against a former compliance director at London Capital & Finance for allegedly approving misleading promotions that led to investor deception.
More from Regulatory Enforcement
-
News BriefFTC complaint accuses LA Fitness parent companies of blocking easy membership exits
The Federal Trade Commission filed a complaint against LA Fitness’ parent companies, citing difficulties canceling memberships, a month after a court blocked the agency’s click-to-cancel rule.
-
ArticleJudge orders CVS to pay nearly $290M for Medicare false claims
CVS’s Caremark division knowingly overcharged Medicare for prescription drugs and must pay nearly $290 million, a Pennsylvania federal judge has ordered.
-
News BriefSEC charges duo in $275 million water vending machine Ponzi scheme
The owner of a water machine vending company and a portfolio manager were allegedly behind a Ponzi-like scheme that raised more than $275 million, according to the U.S. Securities and Exchange Commission.